Live Breaking News & Updates on Joe Pantginis|Page 2

Stay updated with breaking news from Joe pantginis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , William Wood , Jill Howe , David Thelander , Al Kingsley , Joe Pantginis , Mayank Mamtani , Brian Culley , Jack Allen , Dana Red Foundation , California Institute For Regenerative Medicine , Global Head Of Ophthalmology Product Development , Lineage Cell Therapeutics Inc , Lineage Cell Therapeutics , Call Transcript May , Cell Therapeutics , Lineage Cell Therapeutics First Quarter , Ioana Hone , Investor Relations , Chief Executive Officer , Chief Financial , Opregen Phase , Vice President , Global Head , Ophthalmology Product Development , California Institute ,

BiomX Inc. (AMEX:PHGE) Q4 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the BiomX Full Year 2023 Financial Results and Corporate Update Conference Call. Currently, all participants are in a listen-only mode. ....

Michael Higgins , Avi Gabay , Jonathan Solomon , Joe Pantginis , Action Fund , Biomx Inc , Ladenburg Thalmann , Cystic Fibrosis Foundation , Cf Foundation , Call Transcript April , Biomx Full Year , Corporate Update Conference , Interim Chief Financial Officer , Investors Section , Safe Harbor , Adaptive Phage Therapeutics , Chief Executive Officer , Deerfield Management , Disease Control , Methicillin Resistant Staphylococcus , Growing Economies , Jim Cramer , Talking About Trump Media ,

Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2023 Earnings Call Transcript

Operator: Greetings. Welcome to Panbela Therapeutics Fourth Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. ....

United States , Jennifer Simpson , Josh Korsen , Jonathan Aschoff , Joe Pantginis , Eflornithine Pediatric Neuroblastoma Program , American Society Of Hematology , Stock Market Exchange , Moffitt Cancer Center , University Of Texas Md Anderson Cancer Center , Panbela Therapeutics Inc , National Cancer Institute , Diabetes Research Foundation , Indiana University School Of Medicine , Oncology Group , College Education , Children Oncology Group , John Hopkins University School Of Medicine , Syngene International Ltd , Panbela Therapeutics , Call Transcript March , Panbela Therapeutics Fourth Quarter , James Carbonara , Chief Executive Officer , Sue Horvath , Chief Financial ,

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode. ....

United States , Tim Lugo , Gavin Clark Gartner , Christine Wilson , Alec Stranahan , Debjit Chattopadhyay , Joe Pantginis , Suma Krishnan , Krish Krishnan , Kate Romano , William Blair , Krystal Biotech Inc , European Medical Agency , Goldman Sachs , Cystic Fibrosis Foundation , Most Valuable Tobacco Companies , Device Agency , Corporate Communications , Japan Pharmaceuticals , Krystal Biotech , Call Transcript February , Krystal Biotech Fourth Quarter , Full Year , Meg Dodge , Investor Relations , Chief Executive Officer ,

Cadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

PONTE VEDRA, Fla., Jan. 24, 2024 /PRNewswire/ Cadrenal Therapeutics, Inc., , a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant designed to. ....

Douglas Losordo , Robert Blum , Matthew Szot , Joe Pantginis , Prnewswire Cadrenal Therapeutics Inc , Cadrenal Therapeutics Inc , Company Webcast , Hc Wainwright Co , Lytham Partners , Chief Medical Officer , Managing Director , Vitamink Antagonist ,